[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651891":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":31,"centralContacts":38,"locations":44,"responsibleParty":65,"collaborators":31,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":31,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":31,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":31,"overallStatus":46,"whyStopped":31,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Kafrelsheikh University","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Group I (Negative Control)","ACTIVE_COMPARATOR","Patients will receive gel foam only",[13],"Drug: Gel foam",{"label":15,"type":16,"description":17,"interventionNames":18},"Group II (Study Group 1)","EXPERIMENTAL","Patients will receive 0.2% thymoquinone gel + gel foam.",[19],"Drug: Thymoquinone gel + gel foam",{"label":21,"type":16,"description":22,"interventionNames":23},"Group III (Study Group 2, Nano)","Patients will receive nano-formulated 0.2% thymoquinone gel + gel foam.",[24],"Drug: Nano-formulated 0.2% thymoquinone gel + gel foam",[26,32,35],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","Gel foam","Patients will receive gel foam only.",[9],null,{"type":27,"name":33,"description":17,"armGroupLabels":34,"otherNames":31},"Thymoquinone gel + gel foam",[15],{"type":27,"name":36,"description":22,"armGroupLabels":37,"otherNames":31},"Nano-formulated 0.2% thymoquinone gel + gel foam",[21],[39],{"name":40,"role":41,"phone":42,"phoneExt":31,"email":43},"Muataz A Karimeh, Bachelor","CONTACT","00201027988331","moataz.karema1998@gmail.com",[45],{"facility":5,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"RECRUITING","Kafr ash Shaykh","Kafrelsheikh","33516","Egypt","EG",{"type":53,"coordinates":54},"Point",[55,56],30.93991,31.11174,{"lat":56,"lon":55},[59,60,63],{"name":40,"role":41,"phone":42,"phoneExt":31,"email":43},{"name":61,"role":62,"phone":31,"phoneExt":31,"email":31},"Mohammed M Hussein, MD","SUB_INVESTIGATOR",{"name":64,"role":62,"phone":31,"phoneExt":31,"email":31},"Ola M El Borady, MD",{"type":66,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"PRINCIPAL_INVESTIGATOR","Muataz Adnan Karimeh","Oral and Maxillofacial Surgery, Faculty of Dentistry, Kafrelsheikh University, Kafrelsheikh, Egypt.","100651891","effect-of-thymoquinone-02-gel-on-bone-density-bone-width-and-socket-preservation-after-tooth-extraction-100651891",false,"NCT07765745","Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preservation After Tooth Extraction","Clinical and Radiographic Evaluation of the Effect of Thymoquinone 0.2% Gel on Bone Density, Bone Width, and Socket Preservation After Tooth Extraction","Inclusion Criteria:\n\n* Age: 18-50 years.\n* Both sexes.\n* Patients requiring extraction of upper posterior teeth will be recruited.\n\nExclusion Criteria:\n\n* Healthy subjects with intact sockets after extraction.\n* Normal mouth opening and good oral hygiene.\n* No systemic conditions affecting bone healing.","ALL","18 Years","50 Years",{"count":80,"type":81},30,"ESTIMATED","INTERVENTIONAL",[84],"NA","This study aims to evaluate the clinical and radiographic effects of 0.2% Thymoquinone gel on bone density, bone width, and socket preservation after tooth extraction.",[87,88,89,90,91,92],"Radiographic Evaluation","Bone Density","Bone Width","Socket Preservation","Tooth Extraction","Thymoquinone","2026-08-10",{"date":95,"type":96},"2026-08-14","ACTUAL",{"date":98,"type":96},"2026-02-01",{"date":100,"type":81},"2027-02-01",{"name":5,"class":6},1]